Keryx announces data from investigator sponsored trial of ferric citrate in advanced CKD
Keryx announced data from an investigator sponsored study that evaluated the use of ferric citrate in patients with advanced chronic kidney disease. At nine months, patients receiving ferric citrate in the non-dialysis period had significant improvements compared to those in the SOC arm. May 25, 2018